Recent events
Recent events tied to this brand in public sources.
Back to profile4 entries
2021
Charles River completes acquisition of Retrogenix
Charles River completed its acquisition of Retrogenix, a contract research organization providing specialized bioanalytical services.
2021
Charles River completes Cognate BioServices acquisition
Charles River Laboratories announced that it completed its previously announced acquisition of Cognate BioServices for approximately $875 million, subject to customary closing adjustments.
2021
Charles River plans to acquire Cognate BioServices
Charles River Laboratories announced plans to acquire Cognate BioServices for approximately $875 million in cash. The proposed transaction was expected to close by the end of the first quarter, subject to regulatory requirements and customary closing conditions.
2020
Charles River Laboratories completes acquisition of Distributed Bio
Charles River Laboratories completed its acquisition of Distributed Bio for up to $104 million, including $83 million upfront and up to $21 million in milestone payments.